DK1179014T3 - Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII - Google Patents
Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIIIInfo
- Publication number
- DK1179014T3 DK1179014T3 DK00921293T DK00921293T DK1179014T3 DK 1179014 T3 DK1179014 T3 DK 1179014T3 DK 00921293 T DK00921293 T DK 00921293T DK 00921293 T DK00921293 T DK 00921293T DK 1179014 T3 DK1179014 T3 DK 1179014T3
- Authority
- DK
- Denmark
- Prior art keywords
- domain
- spa
- derivatives
- factor viii
- human factor
- Prior art date
Links
- 108010088160 Staphylococcal Protein A Proteins 0.000 title abstract 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title abstract 2
- 102000057593 human F8 Human genes 0.000 title abstract 2
- 229960000900 human factor viii Drugs 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901379A SE9901379D0 (sv) | 1999-04-19 | 1999-04-19 | Receptor structures |
| PCT/SE2000/000732 WO2000063243A1 (en) | 1999-04-19 | 2000-04-17 | Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1179014T3 true DK1179014T3 (da) | 2009-04-06 |
Family
ID=20415254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00921293T DK1179014T3 (da) | 1999-04-19 | 2000-04-17 | Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1179014B1 (da) |
| JP (1) | JP4578690B2 (da) |
| AT (1) | ATE417058T1 (da) |
| AU (1) | AU4162400A (da) |
| DE (1) | DE60041052D1 (da) |
| DK (1) | DK1179014T3 (da) |
| SE (1) | SE9901379D0 (da) |
| WO (1) | WO2000063243A1 (da) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005504261A (ja) * | 2001-01-12 | 2005-02-10 | アフィボディ・アーベー | 検出方法 |
| EP1504265B1 (en) * | 2002-04-29 | 2011-11-30 | Affibody AB | Sandwich assay |
| EP1517921B1 (en) * | 2002-06-28 | 2006-06-07 | Domantis Limited | Dual specific ligands with increased serum half-life |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| SE0301936D0 (sv) * | 2003-06-30 | 2003-06-30 | Affibody Ab | New polypeptide |
| ATE416190T1 (de) * | 2003-07-04 | 2008-12-15 | Affibody Ab | Polypeptide mit bindungsaffinität für her2 |
| SE0301987D0 (sv) * | 2003-07-04 | 2003-07-04 | Affibody Ab | New polypeptide |
| GB0524788D0 (en) * | 2005-12-05 | 2006-01-11 | Affibody Ab | Polypeptides |
| WO2008127457A2 (en) | 2006-12-06 | 2008-10-23 | Repligen Corporation | Nucleic acids encoding recombinant protein a |
| US8198043B2 (en) | 2006-12-08 | 2012-06-12 | General Electric Company | Two helix binders |
| US7989216B2 (en) | 2006-12-08 | 2011-08-02 | General Electric Company | Two helix binders |
| US7981691B2 (en) | 2006-12-08 | 2011-07-19 | General Electric Company | Two helix binders |
| US7977118B2 (en) | 2006-12-08 | 2011-07-12 | General Electric Company | Two helix binders |
| JP5622397B2 (ja) | 2007-03-12 | 2014-11-12 | エスバテック− ア ノバルティス カンパニー エルエルシー | 一本鎖抗体の配列に基づく操作および最適化 |
| AU2008267733B2 (en) | 2007-06-25 | 2013-11-14 | Esbatech, An Alcon Biomedical Research Unit Llc | Sequence based engineering and optimization of single chain antibodies |
| DK2158315T3 (da) | 2007-06-25 | 2016-06-06 | Esbatech Alcon Biomed Res Unit | Fremgangsmåder til modificering af antistoffer og modificerede antistoffer med forbedrede funktionelle egenskaber |
| WO2009019117A1 (en) * | 2007-08-03 | 2009-02-12 | Affibody Ab | Igf-1r binding polypeptides and their use |
| GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
| US9556265B2 (en) | 2008-06-25 | 2017-01-31 | Esbatech, An Alcon Biomedical Research Unit Llc | Solubility optimization of immunobinders |
| US8592555B2 (en) | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
| JP5588983B2 (ja) | 2008-08-11 | 2014-09-10 | ウェルズ ファーゴ バンク ナショナル アソシエイション | マルチアームポリマーアルカノエートコンジュゲート |
| EP2323695B1 (en) | 2008-08-19 | 2018-12-05 | Nektar Therapeutics | Complexes of small-interfering nucleic acids |
| SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
| EP2542567B1 (de) | 2010-03-05 | 2020-02-12 | Boehringer Ingelheim International Gmbh | Selektive anreicherung von antikörpern |
| ES2739503T3 (es) | 2010-07-09 | 2020-01-31 | Bioverativ Therapeutics Inc | Moléculas de cadena simple procesables y polipéptidos producidos usándolas |
| US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| WO2012088422A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| WO2012166555A1 (en) | 2011-05-27 | 2012-12-06 | Nektar Therapeutics | Water - soluble polymer - linked binding moiety and drug compounds |
| SG186552A1 (en) | 2011-06-08 | 2013-01-30 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
| EP3939613A1 (en) | 2011-08-11 | 2022-01-19 | ONO Pharmaceutical Co., Ltd. | Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| LT2802606T (lt) | 2012-01-10 | 2018-10-10 | Biogen Ma Inc. | Terapinių molekulių transporto per kraujo-smegenų barjerą padidinimas |
| WO2013175276A1 (en) | 2012-05-23 | 2013-11-28 | Argen-X B.V | Il-6 binding molecules |
| EP3489396B1 (en) | 2012-12-27 | 2021-03-03 | National Institute of Advanced Industrial Science and Technology | Molecule library constructed on the basis of backbone structure of microprotein |
| US9896486B2 (en) * | 2013-07-10 | 2018-02-20 | Ge Healthcare Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| AU2014314214C1 (en) * | 2013-08-28 | 2019-01-24 | Affibody Ab | Binding polypeptides having a mutated scaffold |
| KR20220002325A (ko) | 2019-04-29 | 2022-01-06 | 씨티바 바이오프로세스 알&디 에이비 | 단백질 A에 결합할 수 있는 Fc 영역이 없는 항체 또는 항체 단편을 분리하는 방법 |
| EP3998081A4 (en) | 2019-07-05 | 2023-07-12 | Ono Pharmaceutical Co., Ltd. | TREATMENT OF BLOOD CANCER WITH PD-1/CD3 DUAL SPECIFICITY PROTEIN |
| JP7771749B2 (ja) | 2019-08-08 | 2025-11-18 | 小野薬品工業株式会社 | 二重特異性タンパク質 |
| TW202346359A (zh) | 2022-04-15 | 2023-12-01 | 美商凱維那醫療公司 | 用於治療自體免疫疾病之方法及組合物 |
| US20250249112A1 (en) * | 2022-04-29 | 2025-08-07 | Craig RAMIREZ | Macropinocytosis selective non-binding protein-drug conjugates |
| JP2025517657A (ja) | 2022-05-10 | 2025-06-10 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | シンシチン-1融合タンパク質及び標的細胞へのカーゴ送達のためのその使用 |
| WO2025041077A1 (en) | 2023-08-23 | 2025-02-27 | Sanofi | Ctla-4-based lysosomal degraders and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI86885C (fi) | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
| SE8501050D0 (sv) | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| SE468050C (sv) | 1991-03-15 | 1998-04-27 | Pharmacia & Upjohn Ab | Rekombinant derivat av human faktor VIII |
| SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
-
1999
- 1999-04-19 SE SE9901379A patent/SE9901379D0/xx unknown
-
2000
- 2000-04-17 DK DK00921293T patent/DK1179014T3/da active
- 2000-04-17 DE DE60041052T patent/DE60041052D1/de not_active Expired - Lifetime
- 2000-04-17 AU AU41624/00A patent/AU4162400A/en not_active Abandoned
- 2000-04-17 EP EP00921293A patent/EP1179014B1/en not_active Expired - Lifetime
- 2000-04-17 WO PCT/SE2000/000732 patent/WO2000063243A1/en not_active Ceased
- 2000-04-17 AT AT00921293T patent/ATE417058T1/de not_active IP Right Cessation
- 2000-04-17 JP JP2000612330A patent/JP4578690B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1179014B1 (en) | 2008-12-10 |
| DE60041052D1 (de) | 2009-01-22 |
| AU4162400A (en) | 2000-11-02 |
| ATE417058T1 (de) | 2008-12-15 |
| WO2000063243A1 (en) | 2000-10-26 |
| EP1179014A1 (en) | 2002-02-13 |
| SE9901379D0 (sv) | 1999-04-19 |
| JP2002542259A (ja) | 2002-12-10 |
| JP4578690B2 (ja) | 2010-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1179014T3 (da) | Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII | |
| EP2292273A3 (en) | Remodeling and glycoconjugation of peptides | |
| ATE460429T1 (de) | Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb | |
| DE69838143D1 (de) | Antimikrobielle peptide | |
| SI1346034T1 (sl) | POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA | |
| ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| DK1451224T3 (da) | Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien | |
| ATE193022T1 (de) | Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin | |
| FI972384L (fi) | Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-terminaalisia sulfonyyli- tai amidinosulfonyyliryhmiä | |
| GB0110430D0 (en) | Protein variants and uses thereof | |
| DK1908772T3 (da) | Polypeptider og polynucleinsyrer af phorphorymonas gingivalis | |
| DE60127113D1 (de) | Gd3 mimetische peptide | |
| NO951418D0 (no) | Peptidderivater, deres fremstilling og anvendelse som terapeutika | |
| CY1109946T1 (el) | Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων | |
| SE9003374D0 (sv) | A collagen binding protein as well as its preparation | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| DE69938130D1 (de) | Neue peptide | |
| NO20014130D0 (no) | Epitoper eller mimotoper avledet fra C-<epsilon>2-domenet hos IgE, antagonister derav og deres terapeutiske anvendelser | |
| SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
| NO975130L (no) | <alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1-piperidinbutanolderivater, deres fremstilling og deres anvendelse som antihistaminer, anti-allergimidler og bronchodilatorer | |
| DK1189615T3 (da) | Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner | |
| DK0540574T3 (da) | Antikoagulationspeptider | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
| DE69534738D1 (de) | Leukocyten-aktivierender Faktor |